Innate Pharma【IPH】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.92

買値

1.918

売値

1.96

出来高

36,430

1.914 日の範囲 1.95

1.332 52 週間の範囲 2.80

時価総額

610.887M

前日終値

1.934

始値

1.95

時刻

148

1.92

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

142,999

発行済株式数

318,170,508

配当利回り

PER

-80.67

1 株当たり利益 (EPS)

-0.02

歳入

61.64M

純利益

-7.57M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.innate-pharma.com

本社

Marseille, Bouches-du-rhone, Fra

設立

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker IPH. The last closing price for Innate Pharma was 1.93 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.80 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 615.34 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -80.67.

Innate Pharma annonce sa participation a la 43ème J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que son équipe de direction présentera et animera des réunions lors de...

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Findings reveal promising early signs that lacutamab may help alleviate some of the most distressing symptoms of cutaneous T cell lymphomas Regulatory News: Innate Pharma SA (Euronext Paris:...

Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma

Innate will receive 3m USD upfront plus up to 4.9m USD in conditional tranched investments from The Institute for Follicular Lymphoma Innovation (IFLI) Patients with R/R Follicular Lymphoma will...

Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that abstracts related to lacutamab health-related quality of life and...

Innate Pharma Releases Its 2025 Financial Calendar

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2025 financial calendar: March 27, 2025: Publication of 2024 financial...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.19	-9.00473933649	2.11	2.11	1.9	181850	1.99875941	DE
4	0.47	32.4137931034	1.45	2.49	1.332	268270	1.82387883	DE
12	-0.1	-4.9504950495	2.02	2.49	1.332	142999	1.76530092	DE
26	-0.13	-6.34146341463	2.05	2.49	1.332	88205	1.83773814	DE
52	-0.6	-23.8095238095	2.52	2.8	1.332	85156	2.10797006	DE
156	-2.47	-56.2642369021	4.39	4.73	1.332	137421	2.72716849	DE
260	-3.84	-66.6666666667	5.76	7.48	1.332	253180	3.88976121	DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?

The current share price of Innate Pharma is 1.92 €

How many Innate Pharma shares are in issue?

Innate Pharma has 318,170,508 shares in issue

What is the market cap of Innate Pharma?

The market capitalisation of Innate Pharma is EUR 615.34M

What is the 1 year trading range for Innate Pharma share price?

Innate Pharma has traded in the range of 1.332 € to 2.80 € during the past year

What is the PE ratio of Innate Pharma?

The price to earnings ratio of Innate Pharma is -80.67

What is the cash to sales ratio of Innate Pharma?

The cash to sales ratio of Innate Pharma is 9.91

What is the reporting currency for Innate Pharma?

Innate Pharma reports financial results in EUR

What is the latest annual turnover for Innate Pharma?

The latest annual turnover of Innate Pharma is EUR 61.64M

What is the latest annual profit for Innate Pharma?

The latest annual profit of Innate Pharma is EUR -7.57M

What is the registered address of Innate Pharma?

The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma website address?

The website address for Innate Pharma is www.innate-pharma.com

Which industry sector does Innate Pharma operate in?

Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
EIFDSTour Eiffel DS	0.0432 € (800.00%)	89.74k
SEQUASequana medical NV	2.76 € (33.33%)	1.64M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M
ALPAUPaulic Meunerie SA	1.43 € (16.26%)	17.14k
GNROGeNeuro SA	0.081 € (15.38%)	330.33k
MLSMLSmalto	0.0125 € (-32.43%)	50
ALVIAVialife Sa	13.30 € (-27.72%)	7
MLMADMade	9.25 € (-15.91%)	255
ALALOAcheterLouerFR	0.23 € (-14.81%)	3.92k
ALLPLLepermislibre SA	0.397 € (-11.78%)	3.01k
ATOAtos SE	0.0023 € (-4.17%)	396.59M
BCPBanco Comercial Portugues SA	0.451 € (0.16%)	17.85M
LATLatecoere	0.0094 € (3.30%)	9.13M
ALVERVergnet	0.0021 € (-4.55%)	8.37M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M